Short Interest in WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) Declines By 59.3%

WuXi Biologics (Cayman) Inc. (OTCMKTS:WXXWY) was the target of a large drop in short interest in January. As of January 30th, there was short interest totaling 9,096 shares, a drop of 59.3% from the January 15th total of 22,350 shares. Based on an average daily trading volume, of 54,542 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily trading volume, of 54,542 shares, the days-to-cover ratio is currently 0.2 days.

WuXi Biologics (Cayman) Price Performance

Shares of OTCMKTS:WXXWY traded down $0.09 during midday trading on Friday, reaching $10.33. 2,664 shares of the company were exchanged, compared to its average volume of 53,097. The business’s fifty day moving average is $9.15 and its two-hundred day moving average is $9.02. WuXi Biologics has a one year low of $4.14 and a one year high of $11.21.

About WuXi Biologics (Cayman)

WuXi Biologics (Cayman) Inc, trading OTC as WXXWY, is a global contract research, development and manufacturing organization (CDMO) specializing in biologics. Founded as a spin-out from WuXi AppTec and incorporated in the Cayman Islands in 2017, the company offers end-to-end support across the biologics value chain. Its service portfolio encompasses discovery biology, analytical development, process chemistry and large-scale manufacturing for therapeutic proteins and antibodies.

The firm’s core offerings include the development of monoclonal antibodies, recombinant proteins and cell and gene therapy vectors.